首页 > 最新文献

International Journal of Ayurveda and Pharma Research最新文献

英文 中文
A Single Centric, Open-Label, Non-Randomized Post- Marketing Surveillance Study to Measure the Efficacy and Safety of Petsaffa Tablets in Subjects Suffering From Constipation, Gas and Acidity 一项单一中心、开放标签、非随机的上市后监测研究,旨在测量 Petsaffa 片剂对便秘、胃胀气和胃酸患者的疗效和安全性
Pub Date : 2024-05-04 DOI: 10.47070/ijapr.v12i4.3207
Shreya Verma, Amrish Verma, Jaspal Singh, Hasan Ali Ahmed, Dilip Kadam
Constipation, gas, and acidity are common gastrointestinal issues with a significant global prevalence. Traditional medicine systems like Ayurveda have long utilized medicinal plants to address these concerns. However, clinical validation of their efficacy in patients with constipation has been lacking. Objectives: This study aimed to assess the efficacy and safety of Petsaffa tablets, an Ayurvedic formulation containing various herbal ingredients, in relieving constipation, gas, and acidity. Methods: The study, conducted as a single-centric, open-label, non-randomized post-marketing surveillance study, involved 120 subjects with constipation. Subjects were evaluated using inclusion and exclusion criteria and provided Petsaffa tablets for a 14-day intervention. Various parameters, including bowel movement frequency, constipation scores, and subjective assessments, were measured. Vital signs, laboratory safety parameters, and adverse events were also monitored during the study period. Results: Petsaffa tablets significantly improved bowel movement frequency, constipation scores, and subjective symptoms related to constipation. Stool consistency and other associated symptoms such as acidity and gas were also reduced at the end of the study. None of the participants reported any adverse events, and safety parameters remained within normal limits during the study period. Conclusion: Petsaffa tablets offer a promising, safe, and effective alternative option for individuals with common gastrointestinal issues such as constipation, acidity, and gas.
便秘、胃胀气和胃酸是常见的肠胃问题,在全球的发病率很高。长期以来,阿育吠陀等传统医学体系一直利用药用植物来解决这些问题。然而,这些药用植物对便秘患者的疗效一直缺乏临床验证。研究目的本研究旨在评估含有多种草药成分的阿育吠陀制剂 Petsaffa 片剂在缓解便秘、胃气和胃酸方面的疗效和安全性。研究方法该研究是一项单一中心、开放标签、非随机的上市后监测研究,涉及 120 名便秘受试者。根据纳入和排除标准对受试者进行评估,并提供 Petsaffa 药片进行为期 14 天的干预。研究人员测量了各种参数,包括排便频率、便秘评分和主观评估。研究期间还对生命体征、实验室安全参数和不良事件进行了监测。研究结果Petsaffa 药片明显改善了排便频率、便秘评分以及与便秘有关的主观症状。在研究结束时,粪便稠度和其他相关症状(如胃酸和胃气)也有所减轻。在研究期间,所有参与者均未报告任何不良事件,各项安全指标均保持在正常范围内。结论Petsaffa 药片为便秘、胃酸和胃胀气等常见胃肠道问题患者提供了一种安全有效的替代选择。
{"title":"A Single Centric, Open-Label, Non-Randomized Post- Marketing Surveillance Study to Measure the Efficacy and Safety of Petsaffa Tablets in Subjects Suffering From Constipation, Gas and Acidity","authors":"Shreya Verma, Amrish Verma, Jaspal Singh, Hasan Ali Ahmed, Dilip Kadam","doi":"10.47070/ijapr.v12i4.3207","DOIUrl":"https://doi.org/10.47070/ijapr.v12i4.3207","url":null,"abstract":"Constipation, gas, and acidity are common gastrointestinal issues with a significant global prevalence. Traditional medicine systems like Ayurveda have long utilized medicinal plants to address these concerns. However, clinical validation of their efficacy in patients with constipation has been lacking. Objectives: This study aimed to assess the efficacy and safety of Petsaffa tablets, an Ayurvedic formulation containing various herbal ingredients, in relieving constipation, gas, and acidity. Methods: The study, conducted as a single-centric, open-label, non-randomized post-marketing surveillance study, involved 120 subjects with constipation. Subjects were evaluated using inclusion and exclusion criteria and provided Petsaffa tablets for a 14-day intervention. Various parameters, including bowel movement frequency, constipation scores, and subjective assessments, were measured. Vital signs, laboratory safety parameters, and adverse events were also monitored during the study period. Results: Petsaffa tablets significantly improved bowel movement frequency, constipation scores, and subjective symptoms related to constipation. Stool consistency and other associated symptoms such as acidity and gas were also reduced at the end of the study. None of the participants reported any adverse events, and safety parameters remained within normal limits during the study period. Conclusion: Petsaffa tablets offer a promising, safe, and effective alternative option for individuals with common gastrointestinal issues such as constipation, acidity, and gas.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"73 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141013603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deepana and Pachana - An evaluative analysis Deepana 和 Pachana - 评估分析
Pub Date : 2024-05-04 DOI: 10.47070/ijapr.v12i4.3198
Saranya K, Ratheesh P, Surej Subash, Vinitha C, Nimisha Michael
Ayurveda pays utmost importance to Agni as it is the inherent factor behind every change that occurs in the body. The persistent Alpagni is said to be the causative factor for all the diseases. This is why Ama pachana and Agni deepana became the basic line of treatment in many diseases. Detailed and in-depth analysis of various classical references and articles published in reliable web resources has been done on the topic Deepana and Pachana and got some inferences. Pacana has role in conditions of Ama while Deepana in Agnimandya. But in our day to day practice when we have different Oushadha yoga, we can’t discriminate it in the formulations. The range of Deepana and Pachana may vary in each formulation. We may say at the Koshta level Deepana karma improves the Abhyavaharana shakti by stimulating the appetite and Pachana karma improves the Jaranashakthi by improving the digestion.
阿育吠陀极为重视阿格尼,因为它是身体发生各种变化的内在因素。据说,顽固的阿格尼是所有疾病的致病因素。这就是为什么阿玛帕恰纳(Ama pachana)和阿格尼深纳(Agni deepana)成为治疗许多疾病的基本方法。我们对各种经典参考文献和发表在可靠网络资源上的文章进行了详细而深入的分析,并就 Deepana 和 Pachana 这一主题得出了一些推论。Pacana 在 Ama 的治疗中发挥作用,而 Deepana 在 Agnimandya 的治疗中发挥作用。但在我们的日常练习中,当我们有不同的欧沙达瑜伽时,我们无法在配方中对其进行区分。Deepana 和 Pachana 的范围在每种配方中都可能不同。我们可以说,在 Koshta 层次上,Deepana karma 通过刺激食欲来改善 Abhyavaharana shakti,而 Pachana karma 则通过改善消化来改善 Jaranashakthi。
{"title":"Deepana and Pachana - An evaluative analysis","authors":"Saranya K, Ratheesh P, Surej Subash, Vinitha C, Nimisha Michael","doi":"10.47070/ijapr.v12i4.3198","DOIUrl":"https://doi.org/10.47070/ijapr.v12i4.3198","url":null,"abstract":"Ayurveda pays utmost importance to Agni as it is the inherent factor behind every change that occurs in the body. The persistent Alpagni is said to be the causative factor for all the diseases. This is why Ama pachana and Agni deepana became the basic line of treatment in many diseases. Detailed and in-depth analysis of various classical references and articles published in reliable web resources has been done on the topic Deepana and Pachana and got some inferences. Pacana has role in conditions of Ama while Deepana in Agnimandya. But in our day to day practice when we have different Oushadha yoga, we can’t discriminate it in the formulations. The range of Deepana and Pachana may vary in each formulation. We may say at the Koshta level Deepana karma improves the Abhyavaharana shakti by stimulating the appetite and Pachana karma improves the Jaranashakthi by improving the digestion.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"214 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141013064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Hridroga (CVD’S) Hridroga(心血管疾病)的管理
Pub Date : 2024-05-04 DOI: 10.47070/ijapr.v12i4.3202
Manvitha Pagadala, Bikash Maharjan
Hridraya is an epitome of sustenance and co-ordination to maintain Ayu. It is considered as one of the three Marma sthana, and is the seat of Sarira, Buddhi, Indriya, Indriyartha, Saguna atma, Mana, etc so, any deviation in its functioning can be tremendously bereaving. Acharya Charaka, Sushruta, Vagbhata and Bhela have been unanimous regarding Hridaya being the seat of Manas and Buddhi. Hridroga is an ocean full of disease entities. In contemporary medical system, it is known as CVD i.e., Cardio-Vascular Disease. CVDs are the leading cause of death taking an estimated 17.9 million lives in 2019 accounting for whooping 32% of all the global deaths. Most cardiovascular diseases can be prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol. These risk factors can be effectively tackled by the judicious adherence to Dinacharya, Ratricharya, Ritucharya, Sadvritta niyamas, etc. Even in the state of disease, compliance with Sodhana procedures and Oushadhas can lead to alleviation of disease and qualitative improvement in the state of Ayu. This article gives 360° view of Shaman oushadhas related to Hridroga, which is explained by the Apta in various ancient texts.
赫拉瑞亚(Hridraya)是寄托和协调阿尤(Ayu)的缩影。它被认为是三个 "Marma sthana "之一,是 Sarira、Buddhi、Indriya、Indriyartha、Saguna atma、Mana 等的所在地,因此,其功能的任何偏差都会造成巨大损失。阿查里亚-查拉卡(Acharya Charaka)、苏斯鲁塔(Sushruta)、瓦格巴塔(Vagbhata)和比拉(Bhela)一致认为,赫里达亚是马纳斯(Manas)和佛陀(Buddhi)的所在地。Hridroga 是充满疾病实体的海洋。在当代医学体系中,它被称为 CVD,即心血管疾病。据估计,2019 年心血管疾病将夺走 1790 万人的生命,占全球总死亡人数的 32%。大多数心血管疾病都可以通过解决行为风险因素来预防,如吸烟、不健康饮食和肥胖、缺乏运动和酗酒。这些风险因素可以通过明智地遵守 Dinacharya、Ratricharya、Ritucharya、Sadvritta niyamas 等来有效解决。即使在疾病状态下,遵守 Sodhana 程序和 Oushadhas 也能缓解疾病,改善 Ayu 状态。这篇文章从 360° 的角度介绍了阿普塔在各种古籍中解释的与赫里德罗加有关的萨满乌沙达。
{"title":"Management of Hridroga (CVD’S)","authors":"Manvitha Pagadala, Bikash Maharjan","doi":"10.47070/ijapr.v12i4.3202","DOIUrl":"https://doi.org/10.47070/ijapr.v12i4.3202","url":null,"abstract":"Hridraya is an epitome of sustenance and co-ordination to maintain Ayu. It is considered as one of the three Marma sthana, and is the seat of Sarira, Buddhi, Indriya, Indriyartha, Saguna atma, Mana, etc so, any deviation in its functioning can be tremendously bereaving. Acharya Charaka, Sushruta, Vagbhata and Bhela have been unanimous regarding Hridaya being the seat of Manas and Buddhi. Hridroga is an ocean full of disease entities. In contemporary medical system, it is known as CVD i.e., Cardio-Vascular Disease. CVDs are the leading cause of death taking an estimated 17.9 million lives in 2019 accounting for whooping 32% of all the global deaths. Most cardiovascular diseases can be prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol. These risk factors can be effectively tackled by the judicious adherence to Dinacharya, Ratricharya, Ritucharya, Sadvritta niyamas, etc. Even in the state of disease, compliance with Sodhana procedures and Oushadhas can lead to alleviation of disease and qualitative improvement in the state of Ayu. This article gives 360° view of Shaman oushadhas related to Hridroga, which is explained by the Apta in various ancient texts.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"62 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141014064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Rigidity Dominant Parkinson’s Disease Through Ayurvedic Protocol 通过阿育吠陀疗法治疗僵直型帕金森病
Pub Date : 2024-05-04 DOI: 10.47070/ijapr.v12i4.3183
Jesny V Jose, Shylamma T M, Aparna V K
Parkinson's Disease (PD) is a disease with insidious onset and slow progression. It is a neurologic condition that causes motor manifestations namely, bradykinesia, rigidity, resting tremor, postural instability and non-motor symptoms such as depression and dementia. The modern treatment provides some symptomatic relief but any proven means for slowing the progression have not been found yet. This case is of a 64-year-old male patient who presented with complaints of slowness in daily activities, difficulty in raising left upper arm along with heaviness, tremors in both hands, difficulty in speech and movement for 3 years. Complaints were increasing progressively hindering his routine activities. He underwent our IP management for 60 days with follow-up after every 20 days. In every follow-up, the patient reported significant relief in his symptoms and after two months, he was able to perform his routine activities without any help.
帕金森病(PD)是一种起病隐匿、进展缓慢的疾病。它是一种神经系统疾病,会导致运动性表现,即运动迟缓、僵直、静止性震颤、姿势不稳以及抑郁和痴呆等非运动性症状。现代治疗可以缓解一些症状,但尚未找到任何行之有效的方法来减缓病情的发展。本病例是一名 64 岁的男性患者,主诉日常生活迟缓、左上臂抬起困难并伴有沉重感、双手震颤、言语和行动困难,已有 3 年之久。症状逐渐加重,妨碍了他的日常活动。他接受了我们的 IP 治疗 60 天,每 20 天复诊一次。在每次随访中,患者都表示症状明显缓解,两个月后,他可以在没有任何帮助的情况下进行日常活动。
{"title":"Management of Rigidity Dominant Parkinson’s Disease Through Ayurvedic Protocol","authors":"Jesny V Jose, Shylamma T M, Aparna V K","doi":"10.47070/ijapr.v12i4.3183","DOIUrl":"https://doi.org/10.47070/ijapr.v12i4.3183","url":null,"abstract":"Parkinson's Disease (PD) is a disease with insidious onset and slow progression. It is a neurologic condition that causes motor manifestations namely, bradykinesia, rigidity, resting tremor, postural instability and non-motor symptoms such as depression and dementia. The modern treatment provides some symptomatic relief but any proven means for slowing the progression have not been found yet. This case is of a 64-year-old male patient who presented with complaints of slowness in daily activities, difficulty in raising left upper arm along with heaviness, tremors in both hands, difficulty in speech and movement for 3 years. Complaints were increasing progressively hindering his routine activities. He underwent our IP management for 60 days with follow-up after every 20 days. In every follow-up, the patient reported significant relief in his symptoms and after two months, he was able to perform his routine activities without any help.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"69 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141013788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic Management of Vulvovaginal Candidiasis with Local Application of Guduchi-Triphala-Danti Gel 通过局部涂抹 Guduchi-Triphala-Danti 凝胶对外阴阴道念珠菌病进行阿育吠陀疗法治疗
Pub Date : 2024-05-04 DOI: 10.47070/ijapr.v12i4.3180
Chindu B S, Maya Balakrishnan, Giby Thomas
Vulvovaginal candidiasis is the infection of the vaginal mucosa and/or vulva caused by the Candida species, a gram-positive yeast-like fungus. It is the second most common vulvovaginal infection characterized by thick-curdy white-cottage-cheese type vaginal discharge and intense vulvovaginal pruritus. Symptomatically vulvovaginal candidiasis can be compared with Slaishmiki yonivyapat in Ayurveda, the line of management of which is the use of Ruksha and Ushna aushadha. Local application of gel has the advantages of easy administration, more bioavailability of drugs, and prolonged retention without much local irritation. The classical Guduchi-Triphala-Danti pariseka yoga, mentioned in Yonivyapat chikitsa has been modified into a gel form, facilitating self-administration by women. Methodology: Here is a case report of a 31-year-old multiparous woman who presented with complaints of curdy white vaginal discharge associated with itching over the vulvar region for the last 6 months. She was diagnosed with vulvovaginal candidiasis by vaginal swab culture. Intervention with Guduchi-Triphala-Danti gel was carried out for 14 days for 2 consecutive cycles excluding days of menstruation and followed up after the next 30 days without medication. Results: After completion of the treatment protocol there was substantial relief of symptoms like curdy white vaginal discharge and itching over the vulvar region, wet-mount microscopy was negative for pseudohyphae, and the vaginal swab culture showed no growth. Conclusion: Local application of Guduchi-Triphala-Danti gel was found to be effective in the management of vulvovaginal candidiasis.
外阴阴道念珠菌病是由念珠菌(一种革兰氏阳性酵母样真菌)引起的阴道粘膜和/或外阴感染。它是第二种最常见的外阴阴道感染,其特点是阴道分泌物粘稠,呈白色干酪样,外阴瘙痒剧烈。在症状上,外阴阴道念珠菌病可与阿育吠陀中的 Slaishmiki yonivyapat 相提并论,其治疗方法是使用 Ruksha 和 Ushna aushadha。局部涂抹凝胶具有给药方便、药物生物利用度更高、留存时间更长且不会对局部造成太大刺激等优点。Yonivyapat chikitsa 中提到的经典 Guduchi-Triphala-Danti pariseka yoga 已被改良为凝胶形式,方便妇女自行用药。方法:这是一例 31 岁多产妇女的病例报告,她主诉在过去 6 个月中阴道有白色卷曲分泌物,并伴有外阴区域瘙痒。经阴道拭子培养,她被诊断为外阴阴道念珠菌病。在连续 2 个周期(不包括月经期)内使用 Guduchi-Triphala-Danti 凝胶进行为期 14 天的干预治疗,并在接下来的 30 天后在不用药的情况下进行随访。结果:治疗方案完成后,阴道白带呈卷曲状、外阴部瘙痒等症状明显缓解,湿装片显微镜检查假丝酵母阴性,阴道拭子培养无生长。结论古都奇-三巴拉-丹提凝胶的局部应用对治疗外阴阴道念珠菌病有效。
{"title":"Ayurvedic Management of Vulvovaginal Candidiasis with Local Application of Guduchi-Triphala-Danti Gel","authors":"Chindu B S, Maya Balakrishnan, Giby Thomas","doi":"10.47070/ijapr.v12i4.3180","DOIUrl":"https://doi.org/10.47070/ijapr.v12i4.3180","url":null,"abstract":"Vulvovaginal candidiasis is the infection of the vaginal mucosa and/or vulva caused by the Candida species, a gram-positive yeast-like fungus. It is the second most common vulvovaginal infection characterized by thick-curdy white-cottage-cheese type vaginal discharge and intense vulvovaginal pruritus. Symptomatically vulvovaginal candidiasis can be compared with Slaishmiki yonivyapat in Ayurveda, the line of management of which is the use of Ruksha and Ushna aushadha. Local application of gel has the advantages of easy administration, more bioavailability of drugs, and prolonged retention without much local irritation. The classical Guduchi-Triphala-Danti pariseka yoga, mentioned in Yonivyapat chikitsa has been modified into a gel form, facilitating self-administration by women. Methodology: Here is a case report of a 31-year-old multiparous woman who presented with complaints of curdy white vaginal discharge associated with itching over the vulvar region for the last 6 months. She was diagnosed with vulvovaginal candidiasis by vaginal swab culture. Intervention with Guduchi-Triphala-Danti gel was carried out for 14 days for 2 consecutive cycles excluding days of menstruation and followed up after the next 30 days without medication. Results: After completion of the treatment protocol there was substantial relief of symptoms like curdy white vaginal discharge and itching over the vulvar region, wet-mount microscopy was negative for pseudohyphae, and the vaginal swab culture showed no growth. Conclusion: Local application of Guduchi-Triphala-Danti gel was found to be effective in the management of vulvovaginal candidiasis.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"10 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141014438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevating the Inner-Consciousness “Third-Eye” Through “Vedic Manas Yoga” Practice 通过 "吠陀摩那瑜伽 "练习提升 "第三只眼 "的内在意识
Pub Date : 2024-05-04 DOI: 10.47070/ijapr.v12i4.3158
Acharya Balkrishna, Prashant Katiyar, Muskan Chauhan, Jaya Upreti, Shubhangi Srivastava, Upasana Aggrawal, Shalini Singh, Vedpriya Arya
‘Third-Eye Chakra’, also known as ‘Ajna Chakra’ in Sanskrit, is the sixth of the body's seven major Chakras. It is also known as the "perception center" and, said to be the seat of soul and the portal to higher awareness. It is essential for achieving greater awareness and serves as the focus of concentration during Asana or meditation practices. Ajna Chakra corresponds to the hypothalamus, pituitary gland, and pineal gland, as well as the eyes, ears, and nose in the physical body. Vedic manas yoga is a holistic approach to yoga that integrates concepts from the Vedas, ancient Indian literature, with practices that attempt to balance the mind, body, and spirit. This study was conducted to develop the inner consciousness and awake the dormant powers of individual participants using Vedic manas yoga. In this observational study, a total 30 physically and mentally healthy subject aged in between 5 to 15 years of both gender from Patanjali Gurukulam, Haridwar, were included. The Pre- and Post-treatment SF-36 scores were statistically evaluated using paired t-test. There was a significant difference (p<0.5) observed in mean scores of Pre-program and Post-program scores of SF-36 after three days programmed interventions against psycho-social, spiritual and emotional development of subjects. The paired t-test revealed a significant score having p<0.05 for pre-program and post-program questionnaire responses. The maximum improvement was recorded to be 22% with overall third-eye activation. Vedic manas yoga practice has shown significant improvement in SF-36 among subjects participating in this study and, further studies are recommended to awaken the inner consciousness and align the energies of body, mind and spirit.
第三眼脉轮 "在梵语中又称 "阿姜那轮",是人体七大脉轮中的第六脉轮。它也被称为 "感知中心",据说是灵魂的所在地和通往更高意识的入口。它是实现更高觉知的关键,也是体式或冥想练习中集中注意力的焦点。阿周那轮与下丘脑、脑垂体、松果体以及身体的眼睛、耳朵和鼻子相对应。吠陀摩那瑜伽是一种综合瑜伽方法,它将古印度文献《吠陀经》中的概念与试图平衡身心和精神的练习融为一体。本研究旨在通过吠陀法那斯瑜伽开发参与者的内在意识,唤醒他们沉睡的力量。在这项观察性研究中,共有 30 名身心健康的男女受试者,年龄在 5 至 15 岁之间,均来自哈里德瓦尔的帕坦伽利古鲁库拉姆(Patanjali Gurukulam)。采用配对 t 检验对治疗前和治疗后的 SF-36 评分进行了统计评估。在对受试者的社会心理、精神和情感发展进行为期三天的方案干预后,观察到方案前和方案后的 SF-36 平均得分存在明显差异(p<0.5)。配对 t 检验显示,计划前和计划后的问卷回答得分显著(P<0.05)。根据记录,受试者第三只眼的整体激活程度提高了 22%。吠陀法那瑜伽练习显示,参与本研究的受试者在 SF-36 方面有明显改善,建议进行进一步研究,以唤醒内在意识,调整身体、心灵和精神的能量。
{"title":"Elevating the Inner-Consciousness “Third-Eye” Through “Vedic Manas Yoga” Practice","authors":"Acharya Balkrishna, Prashant Katiyar, Muskan Chauhan, Jaya Upreti, Shubhangi Srivastava, Upasana Aggrawal, Shalini Singh, Vedpriya Arya","doi":"10.47070/ijapr.v12i4.3158","DOIUrl":"https://doi.org/10.47070/ijapr.v12i4.3158","url":null,"abstract":"‘Third-Eye Chakra’, also known as ‘Ajna Chakra’ in Sanskrit, is the sixth of the body's seven major Chakras. It is also known as the \"perception center\" and, said to be the seat of soul and the portal to higher awareness. It is essential for achieving greater awareness and serves as the focus of concentration during Asana or meditation practices. Ajna Chakra corresponds to the hypothalamus, pituitary gland, and pineal gland, as well as the eyes, ears, and nose in the physical body. Vedic manas yoga is a holistic approach to yoga that integrates concepts from the Vedas, ancient Indian literature, with practices that attempt to balance the mind, body, and spirit. This study was conducted to develop the inner consciousness and awake the dormant powers of individual participants using Vedic manas yoga. In this observational study, a total 30 physically and mentally healthy subject aged in between 5 to 15 years of both gender from Patanjali Gurukulam, Haridwar, were included. The Pre- and Post-treatment SF-36 scores were statistically evaluated using paired t-test. There was a significant difference (p<0.5) observed in mean scores of Pre-program and Post-program scores of SF-36 after three days programmed interventions against psycho-social, spiritual and emotional development of subjects. The paired t-test revealed a significant score having p<0.05 for pre-program and post-program questionnaire responses. The maximum improvement was recorded to be 22% with overall third-eye activation. Vedic manas yoga practice has shown significant improvement in SF-36 among subjects participating in this study and, further studies are recommended to awaken the inner consciousness and align the energies of body, mind and spirit.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"222 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141013042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review on the Effect of An Ayurvedic Management Protocol in Chronic Obstructive Pulmonary Disease 阿育吠陀疗法管理方案对慢性阻塞性肺病的影响综述
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3169
Aswathy M, Jithesh M
Considering the similarities noticed in the etiology and clinical features, COPD can be correlated to Tamaka shvasa among the Pranavaha srotodushti vikara, a condition where Pitta is involved along with Kapha and Vata. Rasayana is the main intervention in such a chronic disease and considering the Doshas and Rasayana, Virecana is the best preparatory Shodhana here to be administered for the patients. In Ayurveda, drug is denoted by the term ‘Bheshaja’ which is defined as the substance through which we can overcome the fear of disease. The ‘Upakarana’ which helps physician for maintaining the healthy condition or to alleviate disorders is said to be Bheshaja. Physician accomplishes the object ‘Vikara shamana’, by giving the appropriate Bheshaja according to different stages and conditions of the patient and disease. According to Ayurveda, action of a drug is based on its Guna, Virya, Vipaka and Prabhava. Fate of the drug always depends on Rasapancaka and it goes in line with modern pharmacodynamics. Besides that, the drug action also depends on the action of agni on that particular drug. In this article, a management protocol review on Chronic Obstructive Pulmonary Disease was carried out. The protocol selected and reviewed was Dipana with Panchakola curna in hot water, Snehapana with Kantakari ghrta, Abhyanga with Tila taila followed by Ushmasveda, Virecana with Vidangatanduladi curna and finally Pippali Vardhamana rasayana.
考虑到病因和临床特征的相似性,慢性阻塞性肺病可与 Pranavaha srotodushti vikara 中的 Tamaka shvasa 相关联,这是一种 Pitta 与 Kapha 和 Vata 共同参与的疾病。Rasayana 是治疗此类慢性疾病的主要方法,考虑到 Doshas 和 Rasayana,Virecana 是为患者提供的最佳预备 Shodhana。在阿育吠陀中,药物用 "Bheshaja "一词来表示,它被定义为可以克服疾病恐惧的物质。帮助医生维持健康状况或缓解疾病的 "Upakarana "就是 "Bheshaja"。医生根据病人和疾病的不同阶段和状况给予适当的 Bheshaja,从而达到 "Vikara shamana "的目的。阿育吠陀认为,药物的作用取决于其Guna、Virya、Vipaka和Prabhava。药物的命运始终取决于 Rasapancaka,这与现代药效学是一致的。除此之外,药物作用还取决于 Agni 对特定药物的作用。本文对慢性阻塞性肺病的治疗方案进行了回顾。所选择和回顾的治疗方案包括在热水中使用 Panchakola curna 的 Dipana、使用 Kantakari ghrta 的 Snehapana、使用 Tila taila 的 Abhyanga,然后是 Ushmasveda、使用 Vidangatanduladi curna 的 Virecana,最后是 Pippali Vardhamana rasayana。
{"title":"Review on the Effect of An Ayurvedic Management Protocol in Chronic Obstructive Pulmonary Disease","authors":"Aswathy M, Jithesh M","doi":"10.47070/ijapr.v12i3.3169","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3169","url":null,"abstract":"Considering the similarities noticed in the etiology and clinical features, COPD can be correlated to Tamaka shvasa among the Pranavaha srotodushti vikara, a condition where Pitta is involved along with Kapha and Vata. Rasayana is the main intervention in such a chronic disease and considering the Doshas and Rasayana, Virecana is the best preparatory Shodhana here to be administered for the patients. In Ayurveda, drug is denoted by the term ‘Bheshaja’ which is defined as the substance through which we can overcome the fear of disease. The ‘Upakarana’ which helps physician for maintaining the healthy condition or to alleviate disorders is said to be Bheshaja. Physician accomplishes the object ‘Vikara shamana’, by giving the appropriate Bheshaja according to different stages and conditions of the patient and disease. According to Ayurveda, action of a drug is based on its Guna, Virya, Vipaka and Prabhava. Fate of the drug always depends on Rasapancaka and it goes in line with modern pharmacodynamics. Besides that, the drug action also depends on the action of agni on that particular drug. In this article, a management protocol review on Chronic Obstructive Pulmonary Disease was carried out. The protocol selected and reviewed was Dipana with Panchakola curna in hot water, Snehapana with Kantakari ghrta, Abhyanga with Tila taila followed by Ushmasveda, Virecana with Vidangatanduladi curna and finally Pippali Vardhamana rasayana.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"15 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140745860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Guggulu Tiktakam Kashayam in Uterine Fibroid Guggulu Tiktakam Kashayam 对子宫肌瘤的疗效
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3159
Swathy Sunil, Giby Thomas, Maya Balakrishnan
The most common benign uterine tumours affecting women in reproductive and perimenopausal stages are fibroids or leiomyomas. There is strong evidence that estrogen and progesterone promote the growth of fibroids, despite the fact that their exact aetiology is still unclear. This is because fibroids seldom arise before menarche and retreat after menopause. The most prevalent reason for hysterectomy is fibroids. Menorrhagia, polymenorrhoea, metrorrhagia, intermenstrual bleeding, infertility, repeated abortions, pain and pressure feelings, abdominal lumps, and vaginal discharge are a few of the symptoms they exhibit clinically. In Ayurveda there is no exact correlation for uterine fibroid. Fibroids can be considered as Mamsa Grandhis, one among the Grandhis described by Charaka and Vagbhata. They increase the surface area of the endometrial tissue in the uterus when present, causing excessive bleeding, pressure feelings, dysmenorrhea, and even infertility. Vata-Kapha predominant Tridoshas have a role in the aetiology of the Granthi Roga, necessitating the use of Vata-kaphahara medicines. As Granthi can also be caused by Mandagni, in Granthi chikitsa we can make use of Dravyas that are Deepana pachana. According to Acharya Susrutha, Sopha Chikitsa is included in the Apakwa Granthi chikitsa. In Mamsa granthi chikitsa, Shothagna, Lekhana, Chedhana, and Vatanulomana dravyas may be utilised. Asrigdara chikitsa and Raktapitta chiktsa can be used to treat fibroids when heavy, prolonged menstrual cycles are present. A 38 year old lady was presented with complaints of heavy, prolonged bleeding during menstruation along with lower abdomen pain. On USG she was diagnosed with uterine fibroids. Guggulu tikitakam kashayam was given for 3 months and after follow up symptoms were evaluated. She was relieved from prolonged heavy bleeding during menstruation and lower abdomen pain. From this case report, it is evident that Guggulu tiktakam kashayam is effective in uterine fibroids
影响生育期和围绝经期妇女的最常见的子宫良性肿瘤是子宫肌瘤或子宫良肌瘤。尽管子宫肌瘤的确切病因尚不清楚,但有确凿证据表明,雌激素和孕激素会促进肌瘤的生长。这是因为子宫肌瘤很少在月经初潮前出现,并在绝经后消退。子宫肌瘤是最常见的子宫切除原因。月经过多、多发性痛经、月经过多、经间期出血、不孕、反复流产、疼痛和压迫感、腹部肿块和阴道分泌物是其临床表现的一些症状。在阿育吠陀中,子宫肌瘤并没有确切的相关性。子宫肌瘤可被视为Mamsa Grandhis,是Charaka和Vagbhata描述的Grandhis之一。子宫肌瘤存在时会增加子宫内膜组织的表面积,导致出血过多、压迫感、痛经甚至不孕。在 Granthi Roga 的病因中,以 Vata-Kapha 为主导的 Tridoshas 起着一定的作用,因此有必要使用 Vata-kaphahara 药物。由于 Granthi 也可能由 Mandagni 引起,因此在 Granthi chikitsa 中,我们可以使用 Deepana pachana 的 Dravyas。根据 Acharya Susrutha 的说法,Sopha Chikitsa 包含在 Apakwa Granthi chikitsa 中。在 Mamsa granthi chikitsa 中,可以使用 Shothagna、Lekhana、Chedhana 和 Vatanulomana Dravyas。当出现月经过多、经期延长时,可以使用 Asrigdara chikitsa 和 Raktapitta chiktsa 治疗子宫肌瘤。一位 38 岁的女士主诉月经期间大量、长时间出血,并伴有下腹疼痛。经 USG 诊断,她患有子宫肌瘤。服用 Guggulu tikitakam kashayam 3 个月,随访后对症状进行了评估。她的月经长期大量出血和下腹疼痛症状得到了缓解。从本病例报告中可以看出,Guggulu tiktakam kashayam 对子宫肌瘤有很好的疗效。
{"title":"Effect of Guggulu Tiktakam Kashayam in Uterine Fibroid","authors":"Swathy Sunil, Giby Thomas, Maya Balakrishnan","doi":"10.47070/ijapr.v12i3.3159","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3159","url":null,"abstract":"The most common benign uterine tumours affecting women in reproductive and perimenopausal stages are fibroids or leiomyomas. There is strong evidence that estrogen and progesterone promote the growth of fibroids, despite the fact that their exact aetiology is still unclear. This is because fibroids seldom arise before menarche and retreat after menopause. The most prevalent reason for hysterectomy is fibroids. Menorrhagia, polymenorrhoea, metrorrhagia, intermenstrual bleeding, infertility, repeated abortions, pain and pressure feelings, abdominal lumps, and vaginal discharge are a few of the symptoms they exhibit clinically. In Ayurveda there is no exact correlation for uterine fibroid. Fibroids can be considered as Mamsa Grandhis, one among the Grandhis described by Charaka and Vagbhata. They increase the surface area of the endometrial tissue in the uterus when present, causing excessive bleeding, pressure feelings, dysmenorrhea, and even infertility. Vata-Kapha predominant Tridoshas have a role in the aetiology of the Granthi Roga, necessitating the use of Vata-kaphahara medicines. As Granthi can also be caused by Mandagni, in Granthi chikitsa we can make use of Dravyas that are Deepana pachana. According to Acharya Susrutha, Sopha Chikitsa is included in the Apakwa Granthi chikitsa. In Mamsa granthi chikitsa, Shothagna, Lekhana, Chedhana, and Vatanulomana dravyas may be utilised. Asrigdara chikitsa and Raktapitta chiktsa can be used to treat fibroids when heavy, prolonged menstrual cycles are present. A 38 year old lady was presented with complaints of heavy, prolonged bleeding during menstruation along with lower abdomen pain. On USG she was diagnosed with uterine fibroids. Guggulu tikitakam kashayam was given for 3 months and after follow up symptoms were evaluated. She was relieved from prolonged heavy bleeding during menstruation and lower abdomen pain. From this case report, it is evident that Guggulu tiktakam kashayam is effective in uterine fibroids","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"37 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140742842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of In Vitro and In Vivo Antioxidant Potential of the Ethyl Acetate Fraction of Cyperus Pangorei Rhizome 评估香附根茎乙酸乙酯馏分的体外和体内抗氧化潜力
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3152
Biswajit Samanta, S. K. Gupta, Amal K. Maji
Background and Aim: Antioxidants derived from natural sources, particularly those rich in flavonoids and phenolic compounds, have attracted considerable interest for their potential health benefits in combating oxidative stress-related diseases. This study aimed to evaluate the antioxidant potential of the ethyl acetate (EtAc) fraction obtained from Cyperus pangorei rhizome, focusing on both in vitro and in vivo assessments. Methods: The EtAc fraction was subjected to RP-HPLC analysis to identify and quantify phenolic compounds and flavonoids. Acute toxicity testing was performed to assess the safety profile of the EtAc fraction. In vitro antioxidant activity was determined using DPPH and ABTS+ radical scavenging assays. In vivo evaluation of antioxidant activity was conducted in Triton X-100-induced oxidative stress model in mice, measuring malondialdehyde (MDA) content, glutathione (GSH) levels, and superoxide dismutase (SOD) activity in liver tissues. Results: RP-HPLC analysis confirmed the presence of quercetin, luteolin, and apigenin in the EtAc fraction. The fraction exhibited significant dose-dependent antioxidant activity in both DPPH and ABTS+ assays, with IC50 values indicating potent scavenging effects. In the Triton X-100-induced stress model, administration of the EtAc fraction led to a reduction in MDA levels, restoration of GSH levels, and enhancement of SOD activity in mouse liver tissues. Conclusion: The findings suggest that the EtAc fraction from C. pangorei possesses promising antioxidant properties, as evidenced by its ability to mitigate oxidative stress-related damage both in vitro and in vivo.
背景和目的:天然来源的抗氧化剂,尤其是富含类黄酮和酚类化合物的抗氧化剂,因其在对抗氧化应激相关疾病方面的潜在健康益处而引起了人们的极大兴趣。本研究旨在评估从香附根茎中提取的乙酸乙酯(EtAc)馏分的抗氧化潜力,重点是体外和体内评估。研究方法对乙酸乙酯馏分进行 RP-HPLC 分析,以鉴定和量化酚类化合物和类黄酮。进行急性毒性测试以评估 EtAc 部分的安全性。体外抗氧化活性采用 DPPH 和 ABTS+ 自由基清除试验进行测定。在 Triton X-100 诱导的小鼠氧化应激模型中对抗氧化活性进行了体内评估,测量肝组织中丙二醛 (MDA) 含量、谷胱甘肽 (GSH) 水平和超氧化物歧化酶 (SOD) 活性。结果RP-HPLC分析证实,EtAc馏分中含有槲皮素、木犀草素和芹菜素。该馏分在 DPPH 和 ABTS+ 试验中均表现出明显的剂量依赖性抗氧化活性,其 IC50 值显示出强大的清除效果。在 Triton X-100 诱导的应激模型中,服用 EtAc 部分可降低小鼠肝组织中的 MDA 水平,恢复 GSH 水平,提高 SOD 活性。结论研究结果表明,C. pangorei 的 EtAc 部分具有很好的抗氧化性,其在体外和体内减轻氧化应激相关损伤的能力就证明了这一点。
{"title":"Evaluation of In Vitro and In Vivo Antioxidant Potential of the Ethyl Acetate Fraction of Cyperus Pangorei Rhizome","authors":"Biswajit Samanta, S. K. Gupta, Amal K. Maji","doi":"10.47070/ijapr.v12i3.3152","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3152","url":null,"abstract":"Background and Aim: Antioxidants derived from natural sources, particularly those rich in flavonoids and phenolic compounds, have attracted considerable interest for their potential health benefits in combating oxidative stress-related diseases. This study aimed to evaluate the antioxidant potential of the ethyl acetate (EtAc) fraction obtained from Cyperus pangorei rhizome, focusing on both in vitro and in vivo assessments. Methods: The EtAc fraction was subjected to RP-HPLC analysis to identify and quantify phenolic compounds and flavonoids. Acute toxicity testing was performed to assess the safety profile of the EtAc fraction. In vitro antioxidant activity was determined using DPPH and ABTS+ radical scavenging assays. In vivo evaluation of antioxidant activity was conducted in Triton X-100-induced oxidative stress model in mice, measuring malondialdehyde (MDA) content, glutathione (GSH) levels, and superoxide dismutase (SOD) activity in liver tissues. Results: RP-HPLC analysis confirmed the presence of quercetin, luteolin, and apigenin in the EtAc fraction. The fraction exhibited significant dose-dependent antioxidant activity in both DPPH and ABTS+ assays, with IC50 values indicating potent scavenging effects. In the Triton X-100-induced stress model, administration of the EtAc fraction led to a reduction in MDA levels, restoration of GSH levels, and enhancement of SOD activity in mouse liver tissues. Conclusion: The findings suggest that the EtAc fraction from C. pangorei possesses promising antioxidant properties, as evidenced by its ability to mitigate oxidative stress-related damage both in vitro and in vivo.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"73 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140741547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic Pharmacology for Mutrakrichra Mutrakrichra 的阿育吠陀药理学
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3171
Sonal Singh Kushwaha, Priya Gupta, Suman Panwar
Mutrakrichra roga (urinary disorders), is a prevalent ailment described in Ayurveda with diverse aetiologies and manifestations. Managing Mutrakrichra (urinary disorders) involves using various herbal drugs with diuretic, lithotriptic, and soothing properties. This study aims to compile and compare the drugs used in treating Mutrakrichra roga (urinary disorders) from different classical Ayurvedic texts or Samhitas, including Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, and other manuscripts. A systematic review of these texts was conducted to identify the drugs recommended for managing Mutrakrichra roga (urinary disorders). The findings revealed a rich repository of medicinal plants and formulations used for their therapeutic effects on urinary disorders, including Gokshura (Tribulus terrestris), Punarnava (Boerrhavia diffusa), and many others. This compilation of drugs from different Samhitas provides valuable insights into the traditional knowledge and practices of Ayurveda in managing Mutrakrichra roga. It underscores the need for further research and clinical studies to validate the efficacy and safety of these herbal remedies in contemporary healthcare practices.
Mutrakrichra roga(泌尿系统疾病)是阿育吠陀中描述的一种常见疾病,其病因和表现多种多样。治疗 Mutrakrichra(泌尿系统疾病)需要使用各种具有利尿、碎石和舒缓作用的草药。本研究旨在汇编和比较不同经典阿育吠陀经文或 Samhitas(包括 Charaka Samhita、Sushruta Samhita、Ashtanga Hridaya 和其他手稿)中用于治疗 Mutrakrichra roga(泌尿系统疾病)的药物。我们对这些典籍进行了系统回顾,以确定推荐用于治疗 Mutrakrichra roga(泌尿系统疾病)的药物。研究结果表明,这些药用植物和配方对泌尿系统疾病具有丰富的治疗效果,其中包括 Gokshura(刺蒺藜)、Punarnava(豕草)等。这本来自不同 Samhitas 的药物汇编为了解阿育吠陀在治疗 Mutrakrichra roga 方面的传统知识和实践提供了宝贵的资料。它强调了进一步研究和临床研究的必要性,以验证这些草药在当代医疗保健实践中的有效性和安全性。
{"title":"Ayurvedic Pharmacology for Mutrakrichra","authors":"Sonal Singh Kushwaha, Priya Gupta, Suman Panwar","doi":"10.47070/ijapr.v12i3.3171","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3171","url":null,"abstract":"Mutrakrichra roga (urinary disorders), is a prevalent ailment described in Ayurveda with diverse aetiologies and manifestations. Managing Mutrakrichra (urinary disorders) involves using various herbal drugs with diuretic, lithotriptic, and soothing properties. This study aims to compile and compare the drugs used in treating Mutrakrichra roga (urinary disorders) from different classical Ayurvedic texts or Samhitas, including Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, and other manuscripts. A systematic review of these texts was conducted to identify the drugs recommended for managing Mutrakrichra roga (urinary disorders). The findings revealed a rich repository of medicinal plants and formulations used for their therapeutic effects on urinary disorders, including Gokshura (Tribulus terrestris), Punarnava (Boerrhavia diffusa), and many others. This compilation of drugs from different Samhitas provides valuable insights into the traditional knowledge and practices of Ayurveda in managing Mutrakrichra roga. It underscores the need for further research and clinical studies to validate the efficacy and safety of these herbal remedies in contemporary healthcare practices.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"25 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140741205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Ayurveda and Pharma Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1